Piershale Financial Group, Inc. Tekla Life Sciences Investors Call Options Transaction History
Piershale Financial Group, Inc.
- $157 Million
- Q2 2023
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding HQL
# of Institutions
76Shares Held
9.04MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$50.8 Million0.82% of portfolio
-
Morgan Stanley New York, NY490KShares$7.25 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA419KShares$6.21 Million0.53% of portfolio
-
Karpus Management, Inc. Pittsford, NY404KShares$5.98 Million0.18% of portfolio
-
Allspring Global Investments Holdings, LLC347KShares$5.13 Million0.01% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...